PEYE Precision Optics Corp. Inc.

Precision Optics Corporation Schedules Third Quarter Conference Call

Precision Optics Corporation Schedules Third Quarter Conference Call

GARDNER, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) today announced that it intends to release its financial results for the fiscal year 2019 third quarter ended March 31, 2019 after market trading ends on Wednesday, May 15, 2019.

Management has scheduled a conference call for 5:00 p.m. Eastern Time on Wednesday, May 15, 2019 to review the Company's financial results and future outlook. Participants may dial into the following number to access the call: 1-844-826-3042 or international callers using 1-412-317-5187. Please ask to be joined into the Precision Optics Corporation conference call. A replay of the call can be accessed until May 22, 2019 at 1-877-344-7529 or 1-412-317-0088 for international callers, and entering Replay Access Code 10130914.

About Precision Optics Corporation

Precision Optics Corporation enables innovation in minimally invasive surgery, diagnostics and treatment through optics and photonics. Precision Optics Corporation has been a leading developer and manufacturer of advanced optical instruments since 1982. Using proprietary optical technologies, the Company designs and produces next generation medical instruments, Microprecision™ micro-optics with characteristic dimensions less than 1 millimeter, and other advanced optical systems for market-leading medical device companies. The Company’s innovative medical instrumentation line includes state-of-the-art endoscopes and endocouplers as well as custom illumination and imaging products for use in minimally invasive surgical procedures. The Company believes that current advances in its proprietary micro-optics and 3D imaging technologies present significant opportunities for expanding applications to numerous potential medical products and procedures. The Company’s website is . Investors can find Real-Time Quotes and market information for the Company on .

Company Contact:

Precision Optics Corporation

22 East Broadway

Gardner, Massachusetts, 01440-3338

Telephone: 978-630-1800

EN
08/05/2019

Underlying

PEYEPrecision Optics Corp. Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Precision Optics Corp. Inc.

 PRESS RELEASE
Free
PEYE Precision Optic...

Precision Optics Corporation Acquires Ross Optical Industries

Precision Optics Corporation Acquires Ross Optical Industries Strategic acquisition expands Precision Optics’ product offering and presence within the U.S. defense sector Company closes $950,000 equity raise tied to acquisition GARDNER, Mass., July 08, 2019 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (“Precision Optics”; the “Company”), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced today that it has completed the acquisition of certain assets of Ross Optical Industries, Inc. (“Ross Optical”...

July 8, 2019 1 EN
 PRESS RELEASE
Free
PEYE Precision Optic...

Precision Optics Corporation, Inc. Announces the Passing of Dr. Kennet...

Precision Optics Corporation, Inc. Announces the Passing of Dr. Kenneth Schwartz GARDNER, Mass., June 19, 2019 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) announced today that Dr. Kenneth Schwartz passed away on June 13, 2019.  Dr. Schwartz was a valued member of the Company’s Board of Directors since 2014. Joe Forkey, Company President and CEO, commented, “We were saddened to learn of the loss of Dr. Ken Schwartz. As a valued member of our Board of Directors for the last five years, Ken provided unique insight into the applicability of our capabi...

June 19, 2019 1 EN
 PRESS RELEASE
Free
PEYE Precision Optic...

Precision Optics Corporation, Inc. Announces Operating Results for the...

Precision Optics Corporation, Inc. Announces Operating Results for the Third Quarter and Nine Months of Fiscal Year 2019 GARDNER, Mass., May 15, 2019 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) today announced operating results on an unaudited basis for its fiscal year 2019 third quarter and nine months ended March 31, 2019. Financial highlights include: Revenues of $1,386,000 in the quarter ended March 31, 2019 compared to $736,000 in the same quarter of the prior year, representing 88% growth;Revenues of $4,424,000 in the nine month...

May 15, 2019 1 EN
 PRESS RELEASE
Free
PEYE Precision Optic...

Precision Optics Corporation Schedules Third Quarter Conference Call

Precision Optics Corporation Schedules Third Quarter Conference Call GARDNER, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) today announced that it intends to release its financial results for the fiscal year 2019 third quarter ended March 31, 2019 after market trading ends on Wednesday, May 15, 2019. Management has scheduled a conference call for 5:00 p.m. Eastern Time on Wednesday, May 15, 2019 to review the Company's financial results and future outlook. Participants may dial into the following number to access the call: 1-844...

May 8, 2019 1 EN
 PRESS RELEASE
Free
PEYE Precision Optic...

Precision Optics Corporation, Inc. Announces Receipt of $2.2 Million O...

Precision Optics Corporation, Inc. Announces Receipt of $2.2 Million Order For Custom Designed Cardiovascular Endoscope GARDNER, Mass., April 29, 2019 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) today announced that it has received a follow-on order totaling $2,216,000 from CardioFocus, Inc. for the manufacture of a cardiovascular endoscope to support the HeartLight Endoscopic Ablation System. Deliveries are scheduled to be made over two years beginning in April 2019. The HeartLight System allows physicians to treat atrial fibrillation with a minimally invasive p...

April 29, 2019 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch